Trademark: IDERA 1754706
Word
IDERA
Device Descrption:
DOT OF LTR I FORMS PART OF MOLECULAR-DIAGRAM
ID
1754706
Trademark Type
Figurative
Status
Cancelled: Cancelled at the request of IB
Application Date
04 January 2016
Registration Date
04 January 2016
Cancellation Date
02 September 2020
Owner(s)
Service
Goods and Services:
Class 5:
Medical therapeutic preparations, namely, biologically active modulators, biologically active immune modulators, biologically active antisense DNA or RNA compounds, chemical modulators of gene expression working at DNA transcription, RNA or translation processes; immunomodulatory oligonucleotides, namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceuticals for use in the treatment of viral and bacterial infection, inflammatory disorders and diseases, asthma or allergies, cancer, and auto immune diseases and disorders and vaccine adjuvants to modulate the immune system; biologically active pharmaceutical compounds for use in the treatment of viral and bacterial infection or diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents or cellular genes
Medical therapeutic preparations, namely, biologically active modulators, biologically active immune modulators, biologically active antisense DNA or RNA compounds, chemical modulators of gene expression working at DNA transcription, RNA or translation processes; immunomodulatory oligonucleotides, namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceuticals for use in the treatment of viral and bacterial infection, inflammatory disorders and diseases, asthma or allergies, cancer, and auto immune diseases and disorders and vaccine adjuvants to modulate the immune system; biologically active pharmaceutical compounds for use in the treatment of viral and bacterial infection or diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents or cellular genes
Class 42:
Medical research; scientific research; biological research; chemical research; medical and scientific research in the area of oligonucleotides or chemical products; pharmaceutical research services; pharmaceutical research and development; product research and development; biological and chemical research in the field of immunology
Medical research; scientific research; biological research; chemical research; medical and scientific research in the area of oligonucleotides or chemical products; pharmaceutical research services; pharmaceutical research and development; product research and development; biological and chemical research in the field of immunology